CA
NZ
UK
AU
IND
US
Pharvaris (NASDAQ:PHVS) shares are up 19.66% in pre-market trading to $42.18, after the company announced statistically significant, positive topline results from its pivotal Phase 3 CHAPTER-3 trial evaluating deucrictibant extended-release tablets for prevention of hereditary angioedema attacks. The stock had closed down 1.15% at …
Roivant Sciences (NASDAQ:ROIV) shares are up 19.81% in pre-market trading to $41.85, after its PulmovantSubsidiaryannounced positive Phase 2 PHocus results for mosliciguat in patients with pulmonary hypertension associated with interstitial lung disease, a condition with limited treatmentOptionsand high unmet need. The stock had closed …
Royalty Pharma (NASDAQ:RPRX) shares are down 7.66% in pre-market trading to $59.06, pulling back sharply from Monday's 52-week high near $64.38, in an apparent contagion move tied to Novartis's (NYSE:NVS) late-stage trial failures. Novartis shares fell sharply after both its del-desiran, for myotonic dystrophy, …
Shares of this NASDAQ-listed commercial-stage biotechnology company are down 12.76% in pre-market trading to $19.63, falling sharply despite the company's own news today being entirely unrelated to clinical trial data. The decline reflects broad contagion across neuromuscular disease and gene therapy stocks after a …
AstraZeneca (NYSE:AZN) shares are up 0.31% in pre-market trading to $163.21, as investors weigh a busy stretch of pipeline and regulatory news against mixed analyst signals and broader healthcare sector weakness. The stock closed down 1.26% at $162.70 the prior session, and today's modest …
Teleflex Incorporated (NASDAQ:TFX) shares slipped at last closing. Teleflex is a maker of single-use medical devices across vascular access, interventional, surgical, urology, and original-equipment and acute-care lines.
● Stevanato Group manufactures glass vials, syringes, cartridges, and drug-delivery devices used to package and administer pharmaceutical products.
● Supernus Pharmaceuticals is a commercial-stage pharmaceutical company focused on central nervous system disease treatments.
Oncolytics Biotech Inc. (NASDAQ:ONCY), a penny stock, fell at last closing. Oncolytics is a clinical-stage biotechnology company built around a single lead asset, pelareorep, an intravenously delivered oncolytic virus and immunotherapy being tested in combination with chemotherapy and immunotherapy across several cancers.
● Nephros designs and sells water filtration products focused on infection control for healthcare facilities and commercial customers.
Please wait processing your request...